跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack
Approved
STANDARD
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
a38a69905aa65393
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
a38a69905aa65393
Product Name
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack
Artg Id
11232
Artg Name
NOLVADEX-D Tamoxifen 20mg (as citrate) tablet blister pack
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
1991-07-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5d44ee9ac90e57a11b2a01614f79b79e.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/a8b302bb3cbfc61ad9066f55f4f3b260.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
a38a69905aa65393
Type
Standard
Back to TGA Approvals